MDI GLYCOPYRROLATE IP 9MCG, FORMOTEROL FUMARATE 4.8MCG & BUDESONIDE IP 160 MCG
Indian Navy · Delhi · Pharmaceuticals · open
Key facts
- Closing date: 17 Aug 2026
- Status: open
- Ministry: Ministry of Defence
- Department: Department of Military Affairs
Description
Tender for supply of inhalation medicines including Glycopyrrolate, Formoterol Fumarate, and Budesonide for the Indian Navy, with a quantity of 450 units, bid validity of 180 days, and scheduled bid opening on 17-08-2026.
Eligibility & requirements
- Startup relaxation: Yes
- MSE relaxation: Yes
- Documents required: Supporting documents for relaxation
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: Item wise evaluation
- Make in India (MII): Yes
- MSE preference: Yes
Line items (1)
- Inhalation medicines including Glycopyrrolate, Formoterol Fumarate, and Budesonide — Qty: 450 unit
1 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Running Contract for Tab/Cap Azelnidipine 16 mg in strip packing. — Pharmaceuticals
- Running Contract for Sodium Chloride 3%, 100 ml Glass Bottle. — Pharmaceuticals
- Running Contract for Salbutamol 2.5 mg /2.5 ml Nebulising Solution 2.5 ml Respule/Amp. — Pharmaceuticals